<DOC>
	<DOCNO>NCT01228188</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety surgical treatment FTMH use inverted ILM reposition improve anatomical functional outcome patient macular hole .</brief_summary>
	<brief_title>Inverted ILM Repositioning Treatment Full Thickness Macular Holes</brief_title>
	<detailed_description>At present , anatomical closure rate macular hole around 90 % use par plana vitrectomy ILM peeling . Improvement visual acuity around 80 % include stage II IV . With macular hole great 400 μm high risk surgical failure visual acuity usually less 0.2 . Large macular hole likely flat-open type closure , anatomical success limit improvement visual acuity . Inverted ILM reposition form scaffold glial cell , allow migration proliferation . This process close macular hole secure re-opening , reduce risk flat-open type closure . The aim study estimate efficiency safety invert ILM reposition treatment macular hole minimum diameter exceed 400 μm compare result currently use method surgical large macular hole treatment .</detailed_description>
	<mesh_term>Retinal Perforations</mesh_term>
	<criteria>fullthickness macular hole minimum diameter exceed 400 μm BCVA 0,3 bad log MAR unit ( &lt; =70 ETDRS letter ) 1,6 good log MAR unit ( &gt; =5 ETRDS letter ) 18 year age Informed consent eye previous vitreous surgery cystoid macular edema cause post traumatic macular hole macular hole associate retinal detachment ocular reason cause lack improvement macular hole surgery ( e.g pigmentary abnormality , agerelated macular degeneration , corneal scar )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>FTMH</keyword>
	<keyword>PPV</keyword>
	<keyword>invert ILM reposition</keyword>
</DOC>